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Abstract
Background: The outcome of first episode schizophrenia has several determinants. Socioecological factors, particularly living
conditions, migration, community and culture, not only affect the level of risk but also the outcome. Mega cities around the
world show a unique socioecological condition that has several challenges for mental health. The present study reports on the
long-term status of patients with schizophrenia in such a mega city: Mumbai, India.
Aim: This study aims to reveal the long-term outcome of patients suffering from schizophrenia with special reference to clinical
symptoms and social functioning.
Methods: The cohort for this study was drawn from a 10-year follow-up of first episode schizophrenia. Patients having
completed 10 years of consistent treatment after first hospitalisation were assessed on psychopathological and recovery criteria.
Clinical as well as social parameters of recovery were evaluated. Descriptive statistics with 95% confidence intervals are
provided.
Results: Of 200 patients recruited at the beginning of this study, 122 patients (61%) were present in the city of Mumbai at the
end of 10-year follow-up study period. Among 122 available patients, 101 patients (50.5%) were included in the assessment at
the end of 10-year follow-up study period, 6 patients (3.0%) were excluded from the study due to changed diagnosis, and 15
patients (7.5%) were excluded due to admission into long-term care facilities. This indicates that 107 out of 122 available patients
(87.7%) were living in the community with their families. Out of 101 (50.5%) patients assessed at the end of 10 years, 61 patients
(30.5%) showed improved recovery on the Clinical Global Impression Scale, 40 patients (20%) revealed no improvement in the
recovery, 43 patients (72.9%) were able to live independently, and 24 patients (40%) were able to find employment.
Conclusion: With 10 years of treatment, the recovery rate among schizophrenia patients in Mumbai was 30.5%. Among the
patients, 87.7% of patients lived in the community, 72.9% of patients lived independently, and 40% of patients obtained
employment. However, 60% of patients were unable to return to work, which highlights the need for continued monitoring and
support to prevent the deterioration of health in these patients. It is likely that socioecological factors have played a role in this
outcome.
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Introduction
The outcome of schizophrenia is highly variable and het-
erogeneous. Despite good treatments, the long-term out-
come of schizophrenia continues to be disappointing [1].
Long-term studies continue to report poor social adjust-
ment, severe functional impairment, and high socioeco-
nomic dependence in early-onset schizophrenia [2] as
well as adult-onset schizophrenia. There are several well
known determinants of outcome including duration of
illness, age of onset, family support, service availability,
personality and genetic factors. It is not quite clear how
clinical, social and cultural factors interact to influence the
short-term and long-term outcome of schizophrenia fol-
lowing treatment. Mega cities present a complex and
unique challenge in service development [3] and social
situation, which are detrimental to mental health. Chang-
ing environment, urban stress, living conditions, housing,
pollution, urban poverty, population density, high cost of
living, high cost of services, isolation from families, over-
crowding, slum dwellings and sanitation are unique chal-
lenges responsible for diversion of funding and budget
leading to poor attention on mental health issues. Poor
accessibility and availability of mental health services,
underutilisation of services, and increased risk and sever-
ity of mental disorders also add complexity to the out-
come of schizophrenia patients in mega cities. The social
determinants of health have been well established [4].
However, a better understanding of the impact of these
factors on outcome of schizophrenia is needed.
Life in Mumbai, India, the fifth most populated city in the
world with 19.2 million people [5], is complex, with mer-
its and constraints to its provisions of psychiatric care. The
city has primary, secondary and tertiary level of services,
near-adequate number of psychiatrists with structured
service provisions from government owned institutions.
In addition, the private sector constitutes a major force in
health care, providing additional emergency psychiatric
facilities. The city has radial access to the network of fam-
ily physicians who utilise a high referral system. The sys-
tem is functional, accessible, available and evolving.
However, people also face complex socioeconomic issues.
Identification, awareness and stigma of mental illness
continue to obstruct diagnosis, early intervention, contin-
ued treatment, people's participation and mental health
promotion. Several factors such as urban poverty, exces-
sive travelling time, long distances, working families,
nuclear families, lack of social security, loneliness, unem-
ployment, temporary job status and burden of caregiving
interfere with accessing available facilities. Resources and
manpower in mental health, however, continue to be less
than adequate. An urban-rural difference in the outcome
of schizophrenia is not a new perspective [6]. Studies have
reported a negative social outcome from urban communi-
ties [7]. It has been repeatedly demonstrated that patients
with schizophrenia often 'drift' toward marginalization in
cities. There is a high prevalence of psychosis amongst the
immigrant population and it is higher in second-genera-
tion immigrants as well [8].
Despite remarkable advancement in treatments, patients
suffering from schizophrenia often do not have satisfac-
tory outcomes in the long run. High rates of suicide
attempt, disability, loss of vocation and inability to adapt
to expected social role are some of the central issues. A
recent study of 13 years of follow-up of early onset schiz-
ophrenia reported acute schizophrenic symptoms in
22.2% of patients and depression symptoms in 30.8% of
patients [9]. The same study revealed that 37% of patients
had tried to commit suicide or had seriously thought
about it, and 77.8% of the former patients were still in
outpatient treatment. Among the patients, 48.1% were
reported to live with their parents, 33.3% lived in assisted
or semiassisted conditions, and 18.5% were working in
the open market [9]. Patients suffering from schizophre-
nia are unable to utilise existing employment opportuni-
ties. Employers neither recruit recovered subjects nor
generate jobs for them. Poor social functioning and
impoverishment lead to non-compliance and relapse,
which further impairs the level of outcome. It is believed
that such non-disease factors are modifiable to enhance
the outcome status in schizophrenia [10]. In mega cities,
unique strategies are required to provide mental health
care that focuses not only on symptom remission but also
on compliance, prevention of relapse, productivity and
social functions. The aim of the present work is to study a
10-year outcome status of patients suffering from schizo-
phrenia with special reference to clinical symptoms and
social functioning in the city of Mumbai, India.
Methods
This naturalistic cross-sectional study was conducted
between 1993 and 2007 in a non-governmental Psychiat-
ric Treatment Centre at Silver Mind Hospital (licensed
centre as per the Indian Mental Health Act 1987), Mum-
bai, India. Ethics permission for this study was obtained
from the local independent research ethics board.
A total of 200 hospitalised first-episode schizophrenia
patients were recruited for a 10-year follow-up study. After
obtaining an appropriate consent, each patient along with
a key relative, was screened for diagnosis. Selected patients
were entered into the study. The patients who were avail-
able (n = 107) at the end point of 10 years were assessed
for recovery using the Clinical Global Impression Scale
(CGIS) [11]. Those patients who showed improved recov-
ery (n = 61) were further reassessed using the Positive and
Negative Syndrome Scale (PANSS) [12] and the Hamilton
Depression Rating Scale (HDRS) [13] for psychopathol-
ogy. Social functioning was assessed using the GlobalAnnals of General Psychiatry 2009, 8:24 http://www.annals-general-psychiatry.com/content/8/1/24
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Assessment of Functioning (GAF) [14] and Quality of Life
(QOL) [15] scales. Status of employment and the ability
to live independently were assessed on a locally devel-
oped measurement scale of 1 to 5. In the status of employ-
ment scale, 1, 2, 3, 4, and 5 means complete dependence,
desire to earn, attempted to earn with failure, attempted to
earn with success, and obtained satisfactory employment,
respectively. In the ability to live independently, 1 means
never lived independently, 2 means occasionally lived
independently, 3 means none of the items mentioned in
scale 5 despite assistance from others, 4 means all of the
items mentioned in scale 5 but with the assistance of rel-
atives, and 5 means able to do daily activities, social func-
tions, work routines and organisations without anyone's
assistance. Cognitive function was assessed using the
Bender-Gestalt (BG) test [16] and the Wechsler Memory
Scale (WMS) [17]. Extrapyramidal symptoms were rated
using the Abnormal Involuntary Movement Scale (AIMS)
[18].
The following inclusion criteria were used: (i) confirmed
diagnosis of schizophrenia as per the Diagnostic and Sta-
tistical Manual, fourth edition (DSM-IV) [14], (ii) com-
pletion of 10 years of treatment with consistent follow-up
and high compliance, (iii) those who scored 1 or 2 on
CGIS indicating much improved and improved recovery
status, (iv) willingness to participate in the assessment, (v)
informed consent, and (vi) availability of a key relative.
The exclusion criteria used in this study include: (i) a his-
tory of significant substance abuse and alcoholism, (ii)
significant head trauma or neurological disorders during
the follow-up period, (iii) any significant medical condi-
tion interfering with social functioning, (iv) poor level of
compliance and inconsistent treatment, and (v) changed
diagnosis. The outcome criteria used in this work are
shown in Table 1. Data collection was performed using
semistructured proforma. The collected data were sub-
jected to descriptive statistics at 95% confidence intervals
to know the treatment outcome on schizophrenia
patients.
Results
Out of 200 patients recruited at the beginning of this
study, 122 patients (61%) were present in the city of
Mumbai at the end of 10-year follow-up study period
(Table 2). Among 122 available patients, 101 patients
(50.5%) were included in the assessment at the end of 10-
year follow-up study period, 6 patients (3.0%) were
excluded from the study due to changed diagnosis, and 15
patients (7.5%) were excluded due to admission into
long-term care facilities. This indicates that 107 out of 122
available patients (87.7%) were living in the community
with their families. The remaining 78 patients (39%) out
of initially enrolled 200 patients were not available for the
assessment due to various reasons: 18 patients (9%)
moved out of Mumbai, 24 patients (12%) switched to
another care provider, 19 patients (9.5%) discontinued
the study, and 17 patients (8.5%) were lost in the follow-
up due to withdrawal of consent and poor compliance.
Out of 101 (50.5%) patients assessed at the end of 10
years, 61 patients (30.5%) showed improved recovery,
and 40 patients (20%) revealed no improvement in recov-
ery on CGIS.
Among the 61 patients who showed improved recovery
(Table 3), 43 patients (70.5%) were male and their mean
age was 42 years; 18 patients (29.5%) were female and
their mean age was 41.5 years. Out of these 61 patients, 43
patients (72.9%) were able to live independently and 24
patients (40%) resumed their employment. Psychopa-
thology was unremarkable, QOL was not very high, GAF
was moderately satisfactory, the level of depression was
mild, and cognition was marginally impaired. Those
patients who did not show excellent recovery were also
able to live in community, within their families, lacking
significant improvement in clinical as well as social func-
tions. They were continuing treatment and did not require
any prolonged stay in hospital or in long-term residential
houses. These patients did not display any significant
threat of violence or lack of self-care or risk to physical
health. Their families were able to work with the distress
and dysfunction expressed by the patients. The families
did not have any financial support from governmental or
non-governmental organisations. The entire responsibil-
ity for care giving, treatments, health and nutrition was
fulfilled by the family members and relatives of the
patients.
Discussion
The present study has shown that the long-term outcome
of schizophrenia in Mumbai is poor. Furthermore, those
patients who showed good outcome continued to live
with disease symptoms and various levels of dysfunction.
Table 1: Operational outcome criteria used in the study
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It appears that recovery is not an 'either/or' concept, but
involves varying degrees and heterogeneity [19]. A good
level of recovery requires total social integration and com-
plete symptom remission. It has been previously recom-
mended that outcome needs to be measured in at least
two dimensions, clinical and social, to provide a more
complete picture of the ability to function [20].
This study raises two pertinent questions: why does the
long-term outcome of schizophrenia continue to be poor,
and why do patients who recover continue to live with
symptoms, distress and dysfunction? Further, there are
two main perspectives arising from the present study, one
shows that the numerical rate of outcome is 30.5% but
27.1% of patients remain dependent on others for living
and 60% of patients do not succeed in gainful employ-
ment. The second and more satisfying perspective is that
majority of these patients (87.7%) are living in the com-
munity within their families; 40% are employed and
72.9% are living independently from the subgroup, which
showed improvement. Even those patients who did not
improve significantly were also able to maintain living in
the community without causing any significant risk.
There have been remarkable developments in the diagno-
sis, treatment, and rehabilitation of patients with schizo-
phrenia. A number of newer drugs and psychosocial
treatments have been found to be effective [21,22]. How-
ever, it appears that these advancements are insufficient to
make a substantial difference for patients suffering from
schizophrenia in this population. Of the 200 patients ini-
tially enrolled in the study, 30.5% were shown to have
experienced improved and much improved outcome
from schizophrenia based on CGIS. Even if we assume
Table 2: Clinical status of schizophrenia patients at the end of 10-year follow-up study period
Clinical status of schizophrenia patients Patients, n (%) 95% Confidence intervals (%)
Total patients recruited at the beginning of study 200 N/A
Total patients available at the end of 10-year study period 122 (61.0%) 54.2 to 68.1
Patients included for follow-up assessment 101 (50.5%) 41.8 to 59.6
Improved 61 (30.5%) 24.2 to 37.4
Not improved 40 (20.0%) 14.7 to 26.2
Patients excluded from follow-up assessment due to changed diagnosis 6 (3.0%) 1.1 to 6.4
Patients excluded from follow-up assessment due to admission in the long-term care 15 (7.5%) 4.3 to 12.1
Total patients not available at the end of 10-year study period for follow-up assessment 78 (39.0%) 33.1 to 45.1
Moved out of Mumbai 18 (9.0%) 5.4 to 13.9
Switched to another care provider 24 (12.0%) 7.8 to 17.3
Discontinued from the study 19 (9.5%) 5.8 to 14.4
Withdrawal of consent and poor compliance 17 (8.5%) 5.0 to 13.3
N/A = not applicable.
Table 3: Characteristics of schizophrenia patients who showed improved recovery at the end of 10-year follow-up study period 
(n = 61)
Characteristics of schizophrenia patients Mean or frequency (SD or %) Range 95% Confidence intervals (%)
Male gender 43.0 (70.5%) - 57.4 to 81.5
Male age (years) 42.0 (7.1) 22 to 58 39.7 to 44.2
Female gender 18.0 (29.5%) - 18.5 to 42.6
Female age (years) 41.5 (8.0) 28 to 55 37.5 to 45.5
PANSS 49.4 (8.2) 31 to 68 47.3 to 51.5
Positive symptoms 8.0 (3.9) 2 to 20 7.0 to 9.0
Negative symptoms 10.1 (7.5) 1 to 27 8.2 to 12.0
General psychopathology 31.0 (12.7) 6 to 57 27.7 to 34.3
HDRS 12.5 (5.3) 4 to 24 11.1 to 13.9
GAF 78.3 (12.2) 45 to 98 75.2 to 81.5
QOL 76.2 (11.5) 46 to 98 73.2 to 79.1
Status of employment (>3) 24.0 (40.0%) 27.6 to 53.5
Independent living (>3) 43.0 (72.9%) 59.7 to 83.6
BG 98.4 (12.8) 78 to 128 95.1 to 101.7
WMS 90.3 (12.2) 68 to 117 87.1 to 93.4
BG = Bender-Gestalt test; GAF = Global Assessment of Functioning; HDRS = Hamilton Depression Rating Scale; PANSS = Positive and Negative 
Syndrome Scale; QOL = Quality of Life; SD = Standard Deviation; WMS = Wechsler Memory Scale.Annals of General Psychiatry 2009, 8:24 http://www.annals-general-psychiatry.com/content/8/1/24
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that those who migrated out of Mumbai city were stabi-
lised and those who discontinued treatment were not
actively ill, this percentage does not exceed 49%. How-
ever, this recovery rate is within the range (16% to 75%)
reported in other long-term studies (Table 4) [20-40].
These results suggest that the long-term outcome of schiz-
ophrenia is similar in all regions and cultures and has not
changed significantly over time.
Although there is considerable literature suggesting geo-
graphical and cultural factors influence risk as well as
recovery from schizophrenia, biological theories continue
to be in the forefront, implying that schizophrenia is a dis-
ease of the brain. Environmental, family and cultural fac-
tors may possibly influence the course of the illness, its
manifestation, psychopathology, relapse, compliance and
severity but not the final outcome of treatment [41]. This
needs to be explored further. Social determinants of men-
tal health play a pivotal role in illness progression but per-
haps not in causation and response to treatment. The
patients in the present cohort began participation with
their first episode of schizophrenia. Patients had access to
multidisciplinary team management, a structured com-
munity program, consistent treatment with atypical antip-
sychotics for at least 3 to 4 years and were highly
compliant with medication, regularly attending psychoso-
cial rehabilitation programs. Despite aggressive manage-
ment, the 10-year recovery rate did not exceed 30.5%. A
more positive side of the study is that the majority of these
patients (87.7%) were able to live in communities with
their families without any significant danger or risk. Only
7.5% of patients needed long-term supervised care. The
Determinants of Outcome of Severe Mental Disorder
(DOSMED) study of the World Health Organization also
highlighted 'uniformity across cultures'. An international
pilot study of schizophrenia carried out in 13 centres
across the world and the DOSMED study showed that
short-term outcome was more favourable in developing
countries than in industrialised nations [42]. A large study
of 18 cohorts reassessing long-term outcome also found
heterogeneity in favourable outcome rates [28]. Unfortu-
nately, an explicit definition of 'favourable' is not given,
but appears to change with changes in social roles and
medical advancements. 'Favourable' is a term which has
carried on from the era when there were few advance-
ments in pharmacotherapy or psychosocial management,
and 'institutionalisation' was the sad reality in mental
health. Parallel to physical health, changing expectations
in mental health have been demanding.
It has also been argued that acute transient psychosis, a
distinct feature of schizophrenia in India, is mostly
responsible for better outcome as suggested in a 12-year
follow-up study, which supported the International Clas-
sification of Diseases (10th revision) concept of a separa-
ble group of acute and transient psychotic disorders [42].
It therefore becomes clear that the short-term course of
schizophrenia is reported to be better in some developing
country settings. The long-term course of the disease in
such settings, however, is not so clear. The DOSMED
study at 2-year and 15-year follow-ups involving a cohort
of first-contact patients in urban and rural Chandigarh,
Table 4: Long-term outcome status of schizophrenia patients reported in the literature
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India showed that 92% of patients with a poor 2-year
course had a poor long-term course and 47% died, a mor-
tality rate nine times higher than patients with other 2-
year course types [43]. The Madras longitudinal study
with 76 patients followed for 10 years revealed that the
clinical outcome was good in nearly 75% of the patients,
with almost all symptoms showing a steep decline by the
end of 10 years. In all, 59 subjects were asymptomatic at
the end of the follow-up period and 12 were ill during the
entire 10th year [44]. When compared to previously pub-
lished findings, the present study shows a long-term good
outcome rate of only 30.5%. This might be due to differ-
ences in the sociocultural milieu. Further studies are
needed to provide more insights.
Another important aspect of the present study is the soci-
ocultural milieu. The study was conducted in the world's
fifth most populated mega city. Traditionally, patients in
developing countries have shown very good outcomes in
terms of clinical remission, less time spent in psychosis,
and lower relapse rates [45]. There is very rich literature
from India about the course, outcome and psychopathol-
ogy, arguing that schizophrenia is transient, acute and
more responsive with subjects being more integrated in
their families. Studies suggest that families make a differ-
ence and contribute to good outcomes in developing
countries, particularly in India, as compared to developed
countries [46-49]. Recently, this premise has been chal-
lenged on the basis of natural selection bias, highlighting
that the outcome of schizophrenia is not as good as previ-
ously projected [30]. It seems clear (and paradoxically so)
that the course and outcome of schizophrenia in develop-
ing countries is deteriorating and getting closer to what is
observed in the industrialised nations [50,51].
The present study further highlights the need to review
outcome measures. When recovered patients were reas-
sessed on the CGIS on multidimensional criteria of symp-
tomatology, social function and employment, it was seen
that 72.9% of patients were able to live independently
and 40% resumed work. Independent living is a suggested
criterion for outcome on multidimensional parameters
[52]. This rate is higher than the 10-year follow-up rate of
56.8% reported in patients with schizophrenia comorbid
with substance abuse in North America [53]. Independent
living does indicate the individual's capacity for managing
his/her life as well as being able to take care of their fam-
ily. It suggests that all 'excellently improved' patients are
unable to take control of their lives indicating a continued
need for the involvement of caregivers, monitoring and
support. It is not possible to say that after withdrawing
support or monitoring whether these subjects would
relapse or deteriorate. Much has been said about the
'return to function' of a person suffering from schizophre-
nia [31]. The traditional impression has been that of
severe disability. In 2007, a Swedish study involving 5
years of follow-up treatment with antipsychotics reported
that only 12% of the patients studied or worked full time
[54]. However, new treatment modalities have made a dif-
ference. It certainly appears from the current study that
patients in India recover better, showing that a sizable
number (40%) have gained successful employment. A
Chinese study reported that, at 10-year follow-up, 54% of
patients with schizophrenia were able to work [55]. This
is a definite improvement from rates reported two decades
earlier. Recovered patients are able to take social roles and
responsibilities. In the present study, it is unclear whether
the 60% of patients who did not return to work were
unemployable or victims of the stigma associated with
mental illness that often leads to prejudice, discrimina-
tion and lack of opportunities. Both issues need to be
addressed. The ability of these patients to work needs to
be assessed as outcome criteria and suitable employment
opportunities need to emerge [56].
The present study demonstrates relatively lower rates of
clinical outcome, implying that schizophrenia may be a
predominantly biological illness with a uniform recovery
rate across cultures and regions. It shows limited social
improvement in the patients, although a reasonable
number return to gainful employment.
Conclusion
The 10-year long-term outcome was studied in schizo-
phrenia patients in Mumbai, India. The recovery rate
among these patients was 30.5%. However, only a small
fraction (7.5%) needed long-term supervised residential
care. The majority of patients (87.7%) were able to live in
the community. Fairly significant numbers of these
patients (72.9%) lived independently and 40% of
patients had obtained gainful employment. All recovered
patients were not able to take control of their life.
Although it is satisfying that a sizable number of patients
returned to employment, there is a clear need for contin-
ued monitoring and support to prevent further decline
and to maintain the level of recovery. Further studies are
required to assess the causes for the low recovery rate in
long-term outcome of schizophrenia.
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